ID   UKF-NB-3rRITA10muM
AC   CVCL_RS21
DR   Wikidata; Q54990354
RX   PubMed=22476102;
WW   https://www.wass-michaelislab.org/rccl.php
CC   Part of: Resistant Cancer Cell Line (RCCL) collection.
CC   Selected for resistance to: ChEBI; CHEBI:94980; [5-[5-[5-(hydroxymethyl)-2-thiophenyl]-2-furanyl]-2-thiophenyl]methanol (RITA).
CC   Derived from site: Metastatic; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3270; Neuroblastoma
DI   ORDO; Orphanet_635; Neuroblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9904 ! UKF-NB-3
SX   Female
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 7
//
RX   PubMed=22476102; DOI=10.1038/cddis.2012.35;
RA   Michaelis M., Rothweiler F., Agha B., Barth S., Voges Y.,
RA   Loschmann N., von Deimling A., Breitling R., Doerr H.-W., Rodel F.,
RA   Speidel D., Cinatl J. Jr.;
RT   "Human neuroblastoma cells with acquired resistance to the p53
RT   activator RITA retain functional p53 and sensitivity to other p53
RT   activating agents.";
RL   Cell Death Dis. 3:e294.1-e294.8(2012).
//